A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Abroad (travel likely)RecruitingPHASE2

Conditions

Hodgkin Lymphoma · B-Cell Lymphoma · Relapsed B-cell NHL

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Jason Westin, MD, MS, FACP) · jwestin@mdanderson.org · 713-792-3750
Contact: Principal Investigator (Jason Westin, MD, MS, FACP)

Study leads

Jason Westin, MD, MS, FACP
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

B-Cell Non-Hodgkin Lymphoma · Burkitt Lymphoma · Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

Relapsed Hodgkin Lymphoma · Refractory Hodgkin Lymphoma · Relapsed Non-Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Indianapolis, United States · Indianapolis, United States

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Acute Myelogenous Leukemia · Acute Lymphatic Leukemia · Chronic Myelogenous Leukemia

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

Classical Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL) · Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Abroad (travel likely)Recruiting

Ancona, Italy · Aviano, Italy